tiprankstipranks
Daré Bioscience Inc (DARE)
NASDAQ:DARE
Holding DARE?
Track your performance easily

Daré Bioscience (DARE) Income Statement

1,811 Followers

Daré Bioscience Income Statement

Last quarter (Q3 2024), Daré Bioscience's total revenue was $41.69K, an increase of Infinity% from the same quarter last year. In Q3, Daré Bioscience's net income was $-4.70M. See Daré Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.07M$ 2.81M$ 10.00M---
Cost of Revenue
------
Gross Profit
$ 1.07M$ 2.81M$ 10.00M---
Operating Expense
$ 27.53M$ 33.75M$ 41.39M$ 39.07M$ 27.40M$ 14.34M
Operating Income
$ -26.46M$ -30.94M$ -31.19M$ -39.07M$ -27.40M$ -14.34M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ -19.42M$ 778.49K$ 437.75K$ -372.41K$ -1.51K$ -81.05K
Pretax Income
$ -6.75M$ -30.16M$ -30.95M$ -38.50M$ -27.23M$ -14.26M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.85M$ -30.16M$ -30.95M$ -38.70M$ -27.41M$ -15.05M
Basic EPS
$ 0.04$ -0.35$ -0.37$ -0.63$ -0.91-
Diluted EPS
$ 0.03$ -0.35$ -0.37$ -0.63$ -0.91$ -0.97
Basic Average Shares
$ 116.37M$ 87.30M$ 84.57M$ 61.15M$ 30.09M$ 15.58M
Diluted Average Shares
$ 116.44M$ 87.30M$ 84.57M$ 61.15M$ 30.09M$ 15.58M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 27.53M$ 33.75M$ 41.39M$ 39.07M$ 27.40M$ 14.34M
Net Income From Continuing And Discontinued Operation
$ -6.85M$ -30.16M$ -30.95M$ -38.70M$ -27.40M$ -14.26M
Normalized Income
$ 1.51M--$ -30.41M--
Interest Expense
------
EBIT
$ -27.19M$ -30.16M$ -31.39M$ -39.07M$ -27.40M$ -14.26M
EBITDA
$ -27.14M$ -30.12M$ -31.36M$ -39.04M$ -27.36M$ -14.25M
Currency in USD

Daré Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis